GMP piroxicam capsules for menstrual cramps
Product Description
Posology
The prescription of Piroxicam should be initiated by physicians with experience in the diagnostic evaluation and treatment of patients with inflammatory or degenerative rheumatic diseases.
The maximum recommended daily dose is 20mg.
Undesirable effects may be minimised by using the minimum effective dose for the shortest duration necessary to control symptoms. The benefit and tolerability of treatment should be reviewed within 14 days. If continued treatment is considered necessary, this should be accompanied by frequent review.
Given that piroxicam has been shown to be associated with an increased risk of gastrointestinal complications, the possible need for combination therapy with gastroprotective agents (e.g. misoprostol or proton pump inhibitors) should be carefully considered, in particular for elderly patients.
Adults: Initially 20mg given as a single daily dose. The majority of patients may be maintained on 20mg a day, a relatively small group of patients may be maintained on 10mg daily.
Children: Not recommended for children under 12 years of age.
Elderly: There are no specific modifications required in the elderly, except where hepatic, renal or cardiac function is impaired, in which case dosage should be individually assessed.
The elderly are at increased risk of the serious consequences of adverse reactions. If an NSAID is considered necessary, the lowest effective dose should be used and for the shortest possible duration. The patient should be monitored regularly for GI bleeding during NSAID therapy.
Method of Administration
For oral administration. To be taken preferably with or after food.
Contact us if you need more details on Piroxicam 20mg Capsules. We are ready to answer your questions on packaging, logistics, certification or any other aspects about Piroxicam Capsules 20mg、Piroxicam 20 Mg Capsule. If these products fail to match your need, please contact us and we would like to provide relevant information.Product Categories : Finished Drugs > Antipyretic Analgesics